Investor Presentaiton

CRLS Key Business Updates (Cont'd) Data Management & Statistical Analysis ("DMSA") . As of June 30, 2023, our DMSA team had over 800 professionals based in China, South Korea, the United States and India As of June 30, 2023, we had 296 DMSA customers and 859 ongoing DMSA projects The project service cooperation mode can be customized according to customer needs Released 5 products of the DIS automation tools in 1H2023, including the Tigermed CRF template, TFL Shell automation tool, SDTM aCRF automation tool, CDISC SDTM Macros and Define Generator tool Completed applications for 14 high-tech software certifications in 1H2023 Laboratory Services The new 8,000 square meters clinical trial manufacturing facility in Suzhou was officially put into operation, further improving our capacity in Good Manufacturing Practice ("GMP”) clinical trial manufacturing and meeting the more diversified customer needs The Wuhan R&D center of ACME Biopharma, a subsidiary of Frontage, was officially opened on May 15, 2023. With a total space of 18,000 square meters, the first phase of the R&D center has a capacity of 50 chemical pharmacology laboratories, 4 formulation development laboratories, and a testing and analysis center, providing one-stop R&D from target screening to pre-clinical pharmacology research On June 6, 2023, our Suzhou Safety Assessment Center obtained the GLP (Good Laboratory Practice) certification issued by the NMPA, which demonstrated that Frontage Suzhou Safety Assessment Center has met the requirements of GLP regulations in terms of organizational structure and personnel training, equipment and computerized systems, laboratory materials, standard operating procedures and test operation ●Tigermed 20 20

View entire presentation